Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LCTX Lineage Cell Therapeutics Inc

休市中 12-20 15:59:55 EST

0.5477

+0.0457

+9.10%

盘后0.5520

-0.0060-1.08%

19:59 EST

最高0.5647	最低0.5051	成交量215.67万
今开0.5211	昨收0.5020	日振幅11.87%
总市值1.21亿	流通市值1.03亿	总股本2.20亿
成交额117.35万	换手率1.15%	流通股本1.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LCTX","market":"US","secType":"STK","nameCN":"Lineage Cell Therapeutics Inc","latestPrice":0.5477,"timestamp":1734728395172,"preClose":0.502,"halted":0,"volume":2156727,"hourTrading":{"tag":"盘后","latestPrice":0.552,"preClose":0.558,"latestTime":"19:59 EST","volume":120390,"amount":67040.4124,"timestamp":1734742783345},"delay":0,"floatShares":188004077,"shares":220416326,"eps":-0.109359,"marketStatus":"休市中","marketStatusCode":7,"change":0.0457,"latestTime":"12-20 15:59:55 EST","open":0.5211,"high":0.5647,"low":0.5051,"amount":1173501.472769,"amplitude":0.118725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.109359,"exchange":"AMEX","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":699771600000,"adjPreClose":0.502,"preHourTrading":{"tag":"盘前","latestPrice":0.5016,"preClose":0.502,"latestTime":"09:22 EST","volume":2544,"amount":1321.7251,"timestamp":1734704579521},"postHourTrading":{"tag":"盘后","latestPrice":0.552,"preClose":0.558,"latestTime":"19:59 EST","volume":120390,"amount":67040.4124,"timestamp":1734742783345},"volumeRatio":1.003365071367098,"impliedVol":0.8848,"impliedVolPercentile":0.5556},"requestUrl":"/m/hq/s/LCTX/tweets","defaultTab":"tweets","newsList":[{"id":"2492440999","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅拉升5.56%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440999?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:28","pubTimestamp":1734708521,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时28分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220232841984cfd8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220232841984cfd8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","LCTX","BK4224","LENZ"],"gpt_icon":0},{"id":"2492187275","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492187275?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:36","pubTimestamp":1734532584,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时36分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cognition Therapeutics, Inc.、Tc Biopharm  Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cognition Therapeutics, Inc.、Tc Biopharm  Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为318.86%、251.56%、92.15%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Tc Biopharm  Plc，振幅分别为66.83%、48.36%、30.87%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822362495ea54c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822362495ea54c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2491544336","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491544336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491544336?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:24","pubTimestamp":1734020694,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时24分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下跌5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002454a1e98583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002454a1e98583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4139","LCTX","BK4224"],"gpt_icon":0},{"id":"2489740234","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489740234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489740234?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:24","pubTimestamp":1733498651,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时24分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.04%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Adc Therapeutics Sa、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Cervomed Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.41%、40.07%、27.52%，振幅较大的相关个股有Adc Therapeutics Sa、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为33.33%、27.68%、26.58%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232411a1d98b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232411a1d98b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","LENZ","BK4224","LCTX"],"gpt_icon":0},{"id":"2489450366","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489450366","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489450366?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:34","pubTimestamp":1733409299,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时34分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1818.92%、252.17%、207.62%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Alx Oncology Holdings Inc.，振幅分别为38.70%、22.62%、12.74%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223459971be18c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223459971be18c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","LINE","BK4224","BK4139"],"gpt_icon":0},{"id":"2488244219","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.05%报0.559美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488244219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488244219?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:43","pubTimestamp":1733251417,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日02时43分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Jupiter Neurosciences Inc涨幅较大，Quoin Pharmaceuticals Ltd、Nls Pharmaceutics Ltd.、Purple Biotech Ltd较为活跃，换手率分别为168.77%、148.10%、145.27%，振幅较大的相关个股有Jupiter Neurosciences Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.75%、69.23%、59.76%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120402433798e52653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120402433798e52653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2488605871","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.95%报0.606美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488605871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488605871?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:21","pubTimestamp":1733156491,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时21分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.95%。截至发稿，该股报0.606美元/股，成交量85.323万股，换手率0.39%，振幅4.90%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203002131a266d044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203002131a266d044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","LENZ","BK4224","BK4139"],"gpt_icon":0},{"id":"2486808549","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.32%报0.573美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486808549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486808549?lang=zh_cn&edition=full","pubTime":"2024-11-28 01:45","pubTimestamp":1732729521,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日01时45分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫5.32%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128014522971a8f12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128014522971a8f12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","BK4224","LINE","LENZ"],"gpt_icon":0},{"id":"2486001599","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速拉升5.00%报0.603美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486001599?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:35","pubTimestamp":1732631751,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时35分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Cabaletta Bio, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、木薯科学较为活跃，换手率分别为13.88%、10.79%、9.44%，振幅较大的相关个股有Cabaletta Bio, Inc.、Fate Therapeutics, Inc.、Caribou Biosciences, Inc.，振幅分别为18.77%、16.32%、15.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223551abe0bea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223551abe0bea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4224","BK4139","LINE"],"gpt_icon":0},{"id":"2486038314","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨6.01%报0.534美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038314?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升6.01%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.70%、60.78%、38.33%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522331898e44650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522331898e44650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","BK4139","LINE","LENZ"],"gpt_icon":0},{"id":"2485916032","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.00%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485916032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485916032?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:27","pubTimestamp":1732296454,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时27分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1842.13%、149.84%、93.34%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为72.75%、71.43%、63.64%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301273498e44354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301273498e44354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ","BK4224","LINE"],"gpt_icon":0},{"id":"2485298756","title":"Lineage Cell Therapeutics, Inc.2024财年第三财季实现净利润-3.03百万美元，同比增加57.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298756?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291393,"startTime":"0","endTime":"0","summary":"11月23日，Lineage Cell Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-3.03百万美元，同比增加57.38%；其中营业收入为3.78百万美元，同比增加202.40%，每股基本收益为-0.02美元。从资产负债表来看，Lineage Cell Therapeutics, Inc.总负债31.80百万美元，其中短期债务1.14百万美元，资产负债比为3.04，流动比率为2.49。机构评级：截至2024年11月23日，当前有6家机构对Lineage Cell Therapeutics, Inc.目标价做出预测，其中目标均价为4.17美元，其中最低目标价为2.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000337a24e49af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000337a24e49af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","LINE"],"gpt_icon":0},{"id":"2485497420","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速跳水5.66%报0.605美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497420?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:39","pubTimestamp":1732199958,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时39分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122391898e43edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122391898e43edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4224","LINE","LCTX"],"gpt_icon":0},{"id":"2484110850","title":"Lineage Cell Therapeutics, Inc.股价重挫19.73% 市值跌2701.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110850?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113078,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速下挫19.73%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为439.66%、130.77%、88.84%，振幅较大的相关个股有Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.、Forte Biosciences, Inc.，振幅分别为17.77%、17.64%、17.55%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311895be4c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311895be4c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","LENZ","BK4224","BK4139"],"gpt_icon":0},{"id":"2484764466","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速上涨5.41%报0.911美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484764466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484764466?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:36","pubTimestamp":1731940563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时36分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.41%。截至发稿，该股报0.911美元/股，成交量3.6726万股，换手率0.02%，振幅2.05%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360395be48b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360395be48b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4224","LINE","LCTX"],"gpt_icon":0},{"id":"2483377366","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377366?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:30","pubTimestamp":1731681013,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨5.08%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Lyra Therapeutics, Inc.、Cybin Inc.、Senti Biosciences, Inc.涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2672.48%、153.67%、44.16%，振幅较大的相关个股有Abvc Biopharma, Inc.、Gain Therapeutics, Inc.、Bioatla, Inc.，振幅分别为4.17%、4.01%、2.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522301498e42ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522301498e42ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2483983992","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近午盘大幅跳水6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483983992?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:39","pubTimestamp":1731515977,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫6.89%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为484.15%、288.62%、105.25%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为88.00%、67.77%、52.89%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114003937971a6574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114003937971a6574&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","BK4139","LENZ","LINE"],"gpt_icon":0},{"id":"2481998143","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速拉升5.03%报0.887美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481998143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481998143?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:09","pubTimestamp":1730905745,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时09分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.03%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1604.05%、179.21%、81.08%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Protagenic Therapeutics, Inc.、Neuraxis, Inc.，振幅分别为73.16%、24.63%、23.51%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623090598e40eb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623090598e40eb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ","BK4224","LINE"],"gpt_icon":0},{"id":"2478867134","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478867134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478867134?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:39","pubTimestamp":1730122777,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时39分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.33%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213938a1f25131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213938a1f25131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4224","LCTX","LINE","BK4139"],"gpt_icon":0},{"id":"2477897913","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.21%报0.860美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477897913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477897913?lang=zh_cn&edition=full","pubTime":"2024-10-22 02:39","pubTimestamp":1729535956,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日02时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下跌5.21%。截至发稿，该股报0.860美元/股，成交量25.2819万股，换手率0.13%，振幅7.21%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022023916971a16dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022023916971a16dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","LINE","BK4224","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lineagecell.com","stockEarnings":[{"period":"1week","weight":0.0824},{"period":"1month","weight":-0.1461},{"period":"3month","weight":-0.4173},{"period":"6month","weight":-0.3935},{"period":"1year","weight":-0.4929},{"period":"ytd","weight":-0.4975}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage Cell Therapeutics, Inc.于1990年在加利福尼亚州成立。该公司是一家临床阶段的生物技术公司，开发新型同种异体或“现成的”细胞疗法，以满足未满足的医疗需求。公司项目基于公司专有的基于细胞的技术平台以及相关的开发和制造能力。从这个平台，该公司设计、开发、制造和测试具有与人体自然发现的细胞相似或相同的解剖和生理功能的专门人体细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.069381},{"month":2,"riseRate":0.294118,"avgChangeRate":-0.036986},{"month":3,"riseRate":0.705882,"avgChangeRate":0.072614},{"month":4,"riseRate":0.294118,"avgChangeRate":-0.076478},{"month":5,"riseRate":0.411765,"avgChangeRate":-0.045447},{"month":6,"riseRate":0.411765,"avgChangeRate":0.010105},{"month":7,"riseRate":0.294118,"avgChangeRate":-0.032338},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.043311},{"month":9,"riseRate":0.5,"avgChangeRate":-0.001843},{"month":10,"riseRate":0.411765,"avgChangeRate":0.657436},{"month":11,"riseRate":0.411765,"avgChangeRate":0.002014},{"month":12,"riseRate":0.588235,"avgChangeRate":0.026465}],"exchange":"AMEX","name":"Lineage Cell Therapeutics Inc","nameEN":"Lineage Cell Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage Cell Therapeutics Inc,LCTX,Lineage Cell Therapeutics Inc股票,Lineage Cell Therapeutics Inc股票老虎,Lineage Cell Therapeutics Inc股票老虎国际,Lineage Cell Therapeutics Inc行情,Lineage Cell Therapeutics Inc股票行情,Lineage Cell Therapeutics Inc股价,Lineage Cell Therapeutics Inc股市,Lineage Cell Therapeutics Inc股票价格,Lineage Cell Therapeutics Inc股票交易,Lineage Cell Therapeutics Inc股票购买,Lineage Cell Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}